Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhi-Cheng Jin

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Hepatology (Baltimore, Md.)|December 22, 2025
Reply: The suggestion for additional clinical scores in decoding tumor heterogeneity in HCCZhi-Cheng Jin, Gao-Jun Teng
Radiology|June 2, 2026
Cisplatin Dose Differences Affect Chemoembolization EfficacyTan-Yang Zhou, Zhi-Cheng Jin, Bin Xiong, et al.
Journal of Hepatocellular Carcinoma|April 28, 2023
A Novel Neutrophil-to-Lymphocyte Ratio and Sarcopenia Based TACE-Predict Model of Hepatocellular Carcinoma PatientsShangyuan Wang, Xuanpu Zhang, Qi Chen, et al.
Hepatology (Baltimore, Md.)|July 15, 2022
Letter to the editor: Hepatitis B virus reactivation in immune checkpoint inhibitor-based combination therapies for hepatocellular carcinomaZhi-Cheng Jin, Jian-Jian Chen, Biao Luo, et al.
Journal of Clinical and Translational Hepatology|January 16, 2023
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular CarcinomaBin-Yan Zhong, Zhi-Cheng Jin, Jian-Jian Chen, et al.
Clinical Interventions in Aging|May 27, 2026
Bronchial Arterial Chemoembolization with versus without Anlotinib in Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Case-Control StudyLinqiang Lai, Tongguo Si, Hongxiang Yao, et al.
Journal of Clinical and Translational Hepatology|January 22, 2024
New First-line Immunotherapy-based Therapies for Unresectable Hepatocellular Carcinoma: A Living Network Meta-analysisJian-Jian Chen, Zhi-Cheng Jin, Biao Luo, et al.
Journal of Nanobiotechnology|December 16, 2025
Engineered macrophage membrane-mimicking nanodrugs activate cGAS/STING pathway to reverse tumor immune suppression after incomplete radiofrequency ablationWei-Hua Zhang, Lei Chen, Lin Gao, et al.
Cardiovascular and Interventional Radiology|March 22, 2022
Efficacy and Safety of Radioactive <sup>125</sup>I Seed Implantation for Patients with Oligo-Recurrence Soft Tissue SarcomasLi Chen, Guang-Yu Zhu, Zhi-Cheng Jin, et al.
Frontiers in Molecular Biosciences|May 13, 2021
Development of TACE Refractoriness Scores in Hepatocellular CarcinomaLi Chen, Chen-Xi Yu, Bin-Yan Zhong, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|December 22, 2025
Reply: The suggestion for additional clinical scores in decoding tumor heterogeneity in HCCZhi-Cheng Jin, Gao-Jun Teng
Radiology|June 2, 2026
Cisplatin Dose Differences Affect Chemoembolization EfficacyTan-Yang Zhou, Zhi-Cheng Jin, Bin Xiong, et al.
Journal of Hepatocellular Carcinoma|April 28, 2023
A Novel Neutrophil-to-Lymphocyte Ratio and Sarcopenia Based TACE-Predict Model of Hepatocellular Carcinoma PatientsShangyuan Wang, Xuanpu Zhang, Qi Chen, et al.
Hepatology (Baltimore, Md.)|July 15, 2022
Letter to the editor: Hepatitis B virus reactivation in immune checkpoint inhibitor-based combination therapies for hepatocellular carcinomaZhi-Cheng Jin, Jian-Jian Chen, Biao Luo, et al.
Journal of Clinical and Translational Hepatology|January 16, 2023
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular CarcinomaBin-Yan Zhong, Zhi-Cheng Jin, Jian-Jian Chen, et al.
Clinical Interventions in Aging|May 27, 2026
Bronchial Arterial Chemoembolization with versus without Anlotinib in Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Case-Control StudyLinqiang Lai, Tongguo Si, Hongxiang Yao, et al.
Journal of Clinical and Translational Hepatology|January 22, 2024
New First-line Immunotherapy-based Therapies for Unresectable Hepatocellular Carcinoma: A Living Network Meta-analysisJian-Jian Chen, Zhi-Cheng Jin, Biao Luo, et al.
Journal of Nanobiotechnology|December 16, 2025
Engineered macrophage membrane-mimicking nanodrugs activate cGAS/STING pathway to reverse tumor immune suppression after incomplete radiofrequency ablationWei-Hua Zhang, Lei Chen, Lin Gao, et al.
Cardiovascular and Interventional Radiology|March 22, 2022
Efficacy and Safety of Radioactive <sup>125</sup>I Seed Implantation for Patients with Oligo-Recurrence Soft Tissue SarcomasLi Chen, Guang-Yu Zhu, Zhi-Cheng Jin, et al.
Frontiers in Molecular Biosciences|May 13, 2021
Development of TACE Refractoriness Scores in Hepatocellular CarcinomaLi Chen, Chen-Xi Yu, Bin-Yan Zhong, et al.
Pageof 3